Brazil Pharmaceuticals & Healthcare Report Q2 2012 - New Market Research Report
BMI View: Brazil remains the most attractive emerging pharmaceutical market in the Americas due to its large population, strong consumer demand, increasing urbanisation and comparatively good drug regulatory environment. Many multinational pharmaceutical companies reported double digital growth during Q411. We expect foreign drugmakers to engage in more collaborations with local companies to capitalise on the rapid market growth and the government's incentives to promote the local industry.
View full press release